173 related articles for article (PubMed ID: 19671689)
1. Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction.
Wilson TJ; Nannuru KC; Singh RK
Mol Cancer Res; 2009 Aug; 7(8):1224-33. PubMed ID: 19671689
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
Nannuru KC; Futakuchi M; Varney ML; Vincent TM; Marcusson EG; Singh RK
Cancer Res; 2010 May; 70(9):3494-504. PubMed ID: 20406980
[TBL] [Abstract][Full Text] [Related]
4. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
5. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells.
Lai CF; Seshadri V; Huang K; Shao JS; Cai J; Vattikuti R; Schumacher A; Loewy AP; Denhardt DT; Rittling SR; Towler DA
Circ Res; 2006 Jun; 98(12):1479-89. PubMed ID: 16709900
[TBL] [Abstract][Full Text] [Related]
6. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
Guise TA; Chirgwin JM
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
[TBL] [Abstract][Full Text] [Related]
9. In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer.
Zhang J; Lu Y; Dai J; Yao Z; Kitazawa R; Kitazawa S; Zhao X; Hall DE; Pienta KJ; Keller ET
Prostate; 2004 Jun; 59(4):360-9. PubMed ID: 15065084
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Bierie B; Stover DG; Abel TW; Chytil A; Gorska AE; Aakre M; Forrester E; Yang L; Wagner KU; Moses HL
Cancer Res; 2008 Mar; 68(6):1809-19. PubMed ID: 18339861
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.
Kuga H; Morisaki T; Nakamura K; Onishi H; Noshiro H; Uchiyama A; Tanaka M; Katano M
Oncogene; 2003 Oct; 22(49):7838-47. PubMed ID: 14586410
[TBL] [Abstract][Full Text] [Related]
12. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo.
Edwards JR; Nyman JS; Lwin ST; Moore MM; Esparza J; O'Quinn EC; Hart AJ; Biswas S; Patil CA; Lonning S; Mahadevan-Jansen A; Mundy GR
J Bone Miner Res; 2010 Nov; 25(11):2419-26. PubMed ID: 20499365
[TBL] [Abstract][Full Text] [Related]
14. Expression of truncated latent TGF-beta-binding protein modulates TGF-beta signaling.
Mazzieri R; Jurukovski V; Obata H; Sung J; Platt A; Annes E; Karaman-Jurukovska N; Gleizes PE; Rifkin DB
J Cell Sci; 2005 May; 118(Pt 10):2177-87. PubMed ID: 15870109
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
16. LTBP-1 blockade in dioxin receptor-null mouse embryo fibroblasts decreases TGF-beta activity: Role of extracellular proteases plasmin and elastase.
Gomez-Duran A; Mulero-Navarro S; Chang X; Fernandez-Salguero PM
J Cell Biochem; 2006 Feb; 97(2):380-92. PubMed ID: 16187295
[TBL] [Abstract][Full Text] [Related]
17. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells.
Safina A; Vandette E; Bakin AV
Oncogene; 2007 Apr; 26(17):2407-22. PubMed ID: 17072348
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway.
Tian YC; Chen YC; Chang CT; Hung CC; Wu MS; Phillips A; Yang CW
Exp Cell Res; 2007 Jul; 313(11):2367-77. PubMed ID: 17467690
[TBL] [Abstract][Full Text] [Related]
20. Activation of transforming growth factor beta in chondrocytes undergoing endochondral ossification.
Dangelo M; Sarment DP; Billings PC; Pacifici M
J Bone Miner Res; 2001 Dec; 16(12):2339-47. PubMed ID: 11760850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
